loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: Granules Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets - Granules India Limited

    MenuGranules India Limited

    Uploaded: 2018
    News
    Granules India gets USFDA nod for generic drug

    17 Dec 2024

    // PRESS RELEASE

    Granules`s Generics Lisdexamfetamine Receives Approval in US

    16 Dec 2024

    // FDA

    Granules India updates on FDA inspection at Gagillapur Facility

    04 Dec 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Granules India

    Contact Supplier

    Website

    Antibody Engineering

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
    Xls

    CATEGORY PAGE
    Menu

    Granules India Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC100397